Physician profile
Kristopher Blake Mccall
NPI 1154682839
$6,191.81
in general payments reported to CMS, 2019-2025
33 companies · $883 in 2025
The $883 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $1,019 · 2021: $2,901 · 2022: $392 · 2023: $304 · 2024: $120 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171 · Travel and Lodging: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.44 |
| Travel and Lodging | $136.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,914.00 | 2021 | |
| Pylant Medical | $1,432.56 | 2019-2025 | |
| Pacira Therapeutics, INC. | $392.88 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $359.66 | 2021-2025 | Mymobility Platform, Gel-One Cross-Linked Hyaluronate |
| Linvatec Corporation | $299.05 | 2025 | Biobrace 23mm, Linvatec 2dhd Video Systems |
| Stryker Corporation | $246.41 | 2022-2025 | Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $193.42 | 2019-2020 | |
| Biopro, INC. | $175.68 | 2019 | |
| Bioventus LLC | $163.19 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System, Durolane |
| Vertex Pharmaceuticals Incorporated | $162.69 | 2025 | |
| Depuy Synthes Sales INC. | $137.59 | 2019-2024 | Monovisc, Orthovisc |
| Catalyst Orthoscience | $121.51 | 2021 | |
| Sanara Medtech INC. | $53.88 | 2022 | |
| Ethicon US, LLC | $52.15 | 2024-2025 | Stratafix |
| Next Science LLC | $51.39 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $49.56 | 2021-2023 | Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $45.66 | 2019 | |
| Fidia Pharma USA INC. | $40.48 | 2019-2024 | Hymovis |
| Davol INC. | $34.56 | 2021 | |
| Trice Medical, INC. | $31.51 | 2023 | |
| Anika Therapeutics, INC. | $25.36 | 2023 | Revomotion |
| Avanos Medical | $24.67 | 2025 | On-Q Pump and Accessories |
| Baxter Healthcare | $22.14 | 2022 | |
| Solventum Corporation | $22.11 | 2024 | V.A.C. Veraflo, Prevena |
| Collegium Pharmaceutical, INC. | $19.94 | 2020 | |
| Urgo Medical North America, LLC | $19.66 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Dynasplint Systems INC. | $16.60 | 2023 | Dynasplint |
| Medtronic USA, INC. | $16.46 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.14 | 2022 | |
| Siemens Medical Solutions USA, INC. | $14.98 | 2019 | |
| Orthofix Medical, INC. | $14.40 | 2025 | Physio-Stim |
| Convatec INC. | $12.73 | 2019 | |
| Ossur Americas, INC. | $9.79 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.